How AI and wearable sensors can keep people healthy for less

As healthcare leaders prioritize reducing costs, one executive believes the way to get there involves wearable devices with sensors, digital assistants and AI, according to a report by The Wall Street Journal.

In the report, Consumer Technology Association President and CEO Gary Shapiro argued that wearable devices that feature sensors have the ability to help keep track of health, body movements and levels, and medications without constantly visiting the doctor. They also allow doctors to monitor patient health from afar and step in when necessary.

“Without asking a single question, your doctor could chart your physical activity and check your hydration, sodium and oxygen levels without using a needle,” Shapiro wrote. “A quick review of your connected prescription dispensers might show you inadvertently skipped a dose of medicine.”

Additionally, AI has the power to analyze tons of data in a short amount of time, while also identifying patterns and abnormalities in patients. he said. The ability can help doctors “make better and more effective decisions” sooner. He also noted that AI-powered smart home technology, like digital assistants, can monitor the health of senior citizens living at home alone, reducing the need for an in-home nurse.

“Seniors living in the United States represent a multibillion-dollar market opportunity, including tech products that help people balance aging with a proactive, healthy, independent lifestyle. As a welcome bonus, these consumer benefits can translate into billions in savings for the healthcare industry,” Shapiro wrote.

To read the full report, click the link below.

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.